The GE Portuguese Journal of Gastroenterology, published by KARGER, is a prominent platform in the field of gastroenterology, providing a vital forum for the dissemination of high-quality research since its establishment. With an open access model implemented in 2012, the journal ensures that emerging findings in gastrointestinal health are readily accessible to a global audience, facilitating the exchange of critical knowledge among researchers, practitioners, and students alike. Based in Switzerland, this journal has earned a respected position within the academic community, currently holding a Q3 ranking in the gastroenterology category for 2023, alongside a Scopus rank of #113 out of 167 in its field. Spanning converged years from 2014 to 2024, the GE Portuguese Journal of Gastroenterology aims to bridge gaps in research and practice, fostering collaboration and innovation across diverse areas within the discipline. Authors and readers alike benefit from the journal's commitment to advancing knowledge and practice in gastroenterology.

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Expert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

The Indian Journal of Gastroenterology, a prominent publication in the field of gastroenterology, is published by Springer India. With roots dating back to 1982 and an ongoing commitment to disseminating high-quality research, this journal serves as a vital platform for researchers, practitioners, and students interested in gastrointestinal health and diseases. It boasts an impressive track record with a Scopus rank of #82 in the gastroenterology category and a 2023 quartile ranking of Q3, firmly situating it within the competitive landscape of medical journals. Although it is not an open-access journal, the Indian Journal of Gastroenterology offers accessible research articles contributing significantly to the field, facilitating informed discussion and advancing knowledge in gastrointestinal medicine. The journal's comprehensive focus covers a wide range of topics from clinical studies to innovative therapeutic approaches, ensuring its relevance to current medical practices and the evolving challenges in gastroenterology.

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.